Michelle Yanez's most recent trade in Mira Pharmaceuticals Inc was a trade of 150,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on Dec. 9, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Mira Pharmaceuticals Inc | Michelle Yanez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 150,000 | 150,000 | - | - | Stock Options (right to buy) | |
Telomir Pharmaceuticals Inc | Michelle Yanez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 200,000 | 200,000 | - | - | Incentive Stock Options (right to buy) | |
Mira Pharmaceuticals Inc | Michelle Yanez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2024 | 150,000 | 57,799 | - | - | Incentive Stock Option (right to buy) | |
Mira Pharmaceuticals Inc | Michelle Yanez | CFO, Secretary and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 20,000 | 20,000 | - | - | Stock Options |